1999
DOI: 10.2165/00044011-199918030-00004
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the 5-HT2A Receptor Antagonist Sarpogrelate in Diabetic Patients with Complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 24 publications
0
6
0
Order By: Relevance
“…In the United Kingdom Prospective Diabetes Study, control of hypertension not only improved macrovascular outcomes but also reduced the incidence of microvascular complications [19]. Moreover, small studies have shown that treatment with vasodilators improves nerve conduction velocity [20,21,22]. …”
Section: Discussionmentioning
confidence: 99%
“…In the United Kingdom Prospective Diabetes Study, control of hypertension not only improved macrovascular outcomes but also reduced the incidence of microvascular complications [19]. Moreover, small studies have shown that treatment with vasodilators improves nerve conduction velocity [20,21,22]. …”
Section: Discussionmentioning
confidence: 99%
“…Hypertension is also an apparent risk factor for sensory neuropathy (Cohen et al., 1998; Emdin et al., 2015; Hebert et al., 2017; Tesfaye et al., 2005). Data indicate pharmacological reduction in BP results in increased nerve conduction velocities (Hotta et al., 1999; Malik et al., 1998; Reja, Tesfaye, Harris, & Ward, 1995). Reduced NO bioavailability (Holowatz & Kenney, 2007a; Taddei, Virdis, Ghiadoni, Magagna, & Salvetti, 1997) and elevated oxidative stress (Holowatz & Kenney, 2007a; Lassegue & Griendling, 2004; Smith et al., 2011) are hallmarks of hypertension and greatly effect microvascular and endothelial function (Holowatz & Kenney, 2007a, 2007b).…”
Section: Discussionmentioning
confidence: 99%
“…In the United Kingdom Prospective Diabetes Study, control of hypertension not only improved macrovascular outcomes but also reduced the incidence of microvascular complications [31]. Moreover, small studies have shown that treatment with vasodilators such as angiotensin‐converting enzyme inhibitors and 5‐HT 2 antagonists improves NCV [32–34]. Antihypertensive treatment with a specific focus on PP reduction might represent a valuable option for the prevention and management of this disabling complication in type 2 diabetes.…”
Section: Discussionmentioning
confidence: 99%